Gastric pH profiles of beagle dogs and their use as an alternative to human testing

M Akimoto, N Nagahata, A Furuya, K Fukushima… - European Journal of …, 2000 - Elsevier
Gastric pH levels were measured in samples of gastric aspirates from eight fasted beagle
dogs. The gastric pH in fasting dogs fluctuated from 2.7 to 8.3, with a mean of 6.8±0.2 (SE) …

Modified release dosage forms of skeletal muscle relaxants

G Venkatesh, JM Clevenger - US Patent 7,387,793, 2008 - Google Patents
(57) ABSTRACT A unit dosage form, such as a capsule or the like, for delivering a skeletal
muscle relaxant, such as cyclobenza prine hydrochloride, into the body in an extended or …

Suitability of the cynomolgus monkey as an animal model for drug absorption studies of oral dosage forms from the viewpoint of gastrointestinal physiology

K Ikegami, K Tagawa, S Narisawa… - Biological and …, 2003 - jstage.jst.go.jp
MATERIALS AND METHODS Materials Acetaminophen (AA) was purchased from
Yamamoto Chemical Co., Ltd.(Japan). Salicylazosulfapyridine (SASP) and sulfapyridine …

Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen …

K Ikegami, K Tagawa, T Osawa - Journal of pharmaceutical sciences, 2006 - Elsevier
To determine the usefulness of monkey as an animal model, bioavailability and in vivo
release behaviors of theophylline (TP) after oral administration of controlled-release beads …

In vitro and in vivo evaluation of a matrix-in-cylinder system for sustained drug delivery

E Mehuys, C Vervaet, I Gielen, H Van Bree… - Journal of controlled …, 2004 - Elsevier
A matrix-in-cylinder system for sustained drug delivery, consisting of a hot-melt extruded
ethylcellulose (EC) pipe surrounding a drug containing HPMC–Gelucire® 44/14 core, was …

Evaluation of gastrointestinal transit controlled-beagle dog as a suitable animal model for bioavailability testing of sustained-release acetaminophen dosage form

K Yamada, A Furuya, M Akimoto, T Maki, T Suwa… - International journal of …, 1995 - Elsevier
In order to develop a suitable beagle dog model for evaluating the bioavailability of a
sustained-release dosage form, we tried to control the gastrointestinal (GI) transit time in …

Modified release dosage forms of skeletal muscle relaxants

G Venkatesh, JM Clevenger - US Patent 7,544,372, 2009 - Google Patents
A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant,
such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release …

[HTML][HTML] Design of prodrugs to enhance colonic absorption by increasing lipophilicity and blocking ionization

R Nofsinger, SD Clas, RI Sanchez, A Walji, K Manser… - Pharmaceuticals, 2014 - mdpi.com
Prodrugs are chemistry-enabled drug delivery modifications of active molecules designed to
enhance their pharmacokinetic, pharmacodynamic and/or biopharmaceutical properties …

In Vivo Performance of an Oral MR Matrix Tablet Formulation in the Beagle Dog in the Fed and Fasted State: Assessment of Mechanical Weakness

F McInnes, N Clear, M Humphrey… - Pharmaceutical …, 2008 - Springer
Purpose To evaluate the behaviour of an oral matrix modified release formulation in the
canine gastrointestinal tract, and establish if a mechanical weakness previously observed in …

Colonoscopic method for estimating the colonic absorption of extended-release dosage forms in dogs

S Tajiri, T Kanamaru, K Yoshida, Y Hosoi… - European Journal of …, 2010 - Elsevier
The purpose of this study was to develop a new method using beagle dogs in order to
evaluate the colonic absorption properties of oral extended-release (ER) solid dosage …